Loading clinical trials...
Loading clinical trials...
The purpose of this investigation was to test the hypothesis that intranasal dexmedetomidine is as effective as second dose of oral chloral hydrate for rescue sedation in infant age between 1 and 6 months who were not adequately sedated following initial dose of chloral hydrate.
Age
0 - 0 years
Sex
ALL
Healthy Volunteers
No
Department of Anesthesiology of Guangzhou Women and Children's Medical Center
Guangzhou, Guangdong, China
Guangzhou Women and Children's Medical Center
Guangzhou, Guangdong, China
Start Date
September 1, 2014
Primary Completion Date
May 1, 2015
Completion Date
May 1, 2015
Last Updated
May 12, 2015
158
ACTUAL participants
chloral hydrate Group
DRUG
low dose dexmedetomidine group
DRUG
high dose dexmedetomidine group
DRUG
Lead Sponsor
Guangzhou Women and Children's Medical Center
NCT01731106
NCT02878837
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT02732132